Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$0.46 - $1.3 $340,016 - $960,917
-739,167 Reduced 82.17%
160,347 $94,000
Q4 2022

Feb 14, 2023

BUY
$0.29 - $0.57 $260,859 - $512,722
899,514 New
899,514 $349,000
Q2 2022

Aug 09, 2022

BUY
$1.58 - $7.36 $712,099 - $3.32 Million
450,696 New
450,696 $712,000

About Tonix Pharmaceuticals Holding Corp.


  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.